Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenal Gland Disorders

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Circadian Rhythms and Gene Regulation

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypopituitarism following severe traumatic brain injury.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2006

Same author

The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2006

Same author

[Subclinical hypothyroidism--what level of TSH is an indication for substitution?].

MMW Fortschritte der Medizin·2006

Same author

Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples.

Molecular psychiatry·2006

Same author

Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006

Same author

Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis.

European journal of endocrinology·2006

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

[Endocrine disorders and the heart].

Onno E Janssen¹, K Mann, R Erbel

¹Klinik für Endokrinologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Deutschland. onno.janssen@uni-due.de

|March 3, 2007

Summary

Endocrine disorders significantly impact heart health, affecting hormone distribution and leading to severe cardiac issues. Hormone replacement therapy has not shown a protective cardiovascular effect in recent studies.

More Related Videos

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Area of Science:

Endocrinology
Cardiology
Cardiovascular Endocrinology

Context:

The cardiovascular system is integral to hormonal regulation, synthesis, and distribution.
Endocrine disorders frequently involve cardiac complications, posing significant risks to patients.
Aberrant hormone function, including thyroid, adrenal, and parathyroid issues, profoundly affects heart health.

Purpose:

To summarize the intricate relationship between endocrine disorders and cardiovascular health.
To highlight the cardiac manifestations of various hormonal imbalances.
To review the current understanding of hormone replacement therapy's cardiovascular impact.

Summary:

Hormonal imbalances from conditions like thyroid dysfunction, diabetes mellitus, acromegaly, Cushing's syndrome, hyperaldosteronism, pheochromocytoma, and hyperparathyroidism critically affect cardiovascular function.
These endocrine disorders can lead to hypertension, metabolic syndrome, cardiomyopathy, and cardiac failure.
The heart's role in hormone distribution underscores its vulnerability to endocrine system disturbances.

Impact:

Understanding these links is crucial for managing patients with both endocrine and cardiovascular diseases.
This knowledge aids in developing targeted treatments for endocrine-related cardiac conditions.
Recent findings challenge the previously assumed cardiovascular benefits of hormone replacement therapy.